Light Adjustable lens (LAL) and Light Delivery Device (LDD)

DEVICE6 trials

Sponsors

RxSight, Inc.

Conditions

AphakiaAphakia CataractCataract

Unknown Phase

Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive Surgery

CompletedNCT03660865

RxSight, Inc.Aphakia, Cataract

Start: 2018-08-28End: 2020-04-01Updated: 2021-12-23

Exploratory Study to Evaluate Uncorrected Distance Vision and Quality of Vision After Light Treatments of an Implanted RxSight Light Adjustable Lens (RXLAL) With The Light Delivery Device (LDD) in Subjects With Preoperative Corneal Astigmatism

CompletedNCT03729024

RxSight, Inc.Aphakia, Cataract

Start: 2018-01-26End: 2020-02-04Updated: 2021-08-06

Exploratory Study to Evaluate the Use of the RxSight Light Adjustable Lens (LAL) and the Light Delivery Device (LDD) to Improve Visual Outcomes

CompletedNCT03895034

RxSight, Inc.Aphakia, Cataract

Start: 2018-06-14End: 2020-03-01Updated: 2022-05-12

Single Center Exploratory Study To Evaluate The Use Of The RxSight Light Adjustable Lens (LAL) And The Light Delivery Device (LDD) To Improve Visual Outcomes

CompletedNCT04529616

RxSight, Inc.Aphakia, Cataract

Start: 2020-05-22End: 2022-10-01Updated: 2025-02-10

RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study

CompletedNCT05202808

RxSight, Inc.Aphakia, Cataract

Start: 2021-12-03End: 2024-12-16Updated: 2025-04-20

Long-Term Clinical Outcomes Of Subjects Enrolled In The RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment Study

Enrolling by invitationNCT07347379

RxSight, Inc.Aphakia Cataract

Start: 2025-11-13End: 2026-12-01Target: 108Updated: 2026-08-12